If Left Unchecked: Lessons Learned from Unfettered U.S. Government Support of the NIH-Moderna Vaccine

Journal of Law, Medicine and Ethics 51 (S2):41-45 (2023)
  Copy   BIBTEX

Abstract

The NIH-Moderna mRNA COVID-19 vaccine’s steep price increase raises concerns that this will be the new anchor for continued price hikes and underscores the need for upstream government intervention to enable greater accountability and stewardship of public biomedical research investment.

Categories

Keywords

Reprint years

DOI

10.1017/jme.2023.155

Other Versions

No versions found

Links

PhilArchive

External links

Setup an account with your affiliations in order to access resources via your University's proxy server

Through your library

My notes

Similar books and articles

Public Returns on Public Investment: Moderna’s Violation of the Social Contract.Ameet Sarpatwari - 2023 - Journal of Law, Medicine and Ethics 51 (S2):28-34.
The NIH-Moderna Vaccine: Public Science, Private Profit, and Lessons for the Future.Christopher J. Morten - 2023 - Journal of Law, Medicine and Ethics 51 (S2):35-40.
From COVID Vaccines to HIV Prevention: Pharmaceutical Financing and Distribution for the Public’s Health.Joshua M. Sharfstein, Rena M. Conti & Rebekah E. Gee - 2022 - Journal of Law, Medicine and Ethics 50 (S1):29-31.
Local Legal Strategies to Increase Vaccination During the COVID-19 Pandemic — Lessons from New York City.Lisa Landau, Naomi Stark & Dave A. Chokshi - 2022 - Journal of Law, Medicine and Ethics 50 (3):613-618.
Lessons from Biomedical Innovation during World War II.Robert Cook-Deegan - 2021 - Hastings Center Report 51 (5):3-3.
Public Attitudes toward COVID-19 Vaccinations before Dawn in Japan: Ethics and Future Perspectives.Haruka Nakada, Kyoko Takashima, Yuichi Maru, Tsunakuni Ikka, Koichiro Yuji, Sachie Yoshida & Kenji Matsui - 2022 - Asian Bioethics Review 14 (3):287-302.
Why Exceptional Public Investment in the Development of Vaccines Is Justified for COVID-19, But Not for Other Unmet Medical Needs.Eline M. Bunnik & Jilles Smids - 2021 - American Journal of Bioethics 21 (12):22-25.
Research ethics and public trust in vaccines: the case of COVID-19 challenge trials.Nir Eyal - 2024 - Journal of Medical Ethics 50 (4):278-284.
COVID-19 vaccine boosters for all adults: An optimal U.s. approach?Ameet Sarpatwari, Ankur Pandya, Emily P. Hyle & Govind Persad - 2022 - Annals of Internal Medicine 175 (2):280-282.
Social network-based ethical analysis of COVID-19 vaccine supply policy in three Central Asian countries.Kerim M. Munir, Totugul Murzabekova, Zhangir Tulekov, Damin Asadov, Daniel Wikler & Timur Aripov - 2022 - BMC Medical Ethics 23 (1):1-8.

Analytics

Added to PP
2024-03-05

Downloads
35 (#1,484,430)

6 months
5 (#1,640,649)

Historical graph of downloads
How can I increase my downloads?

Citations of this work

No citations found.

Add more citations

References found in this work

No references found.

Add more references